[ Price : $8.95]
FDA publishes a regional implementation guide for an International Council on Harmonization document on electronic transmission of...[ Price : $8.95]
FDA accepts for review a Roche supplemental BLA for Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab) plus...[ Price : $8.95]
FDA accepts for priority review an AstraZeneca supplemental NDA for Lynparza (olaparib) in combination with abiraterone and predni...[ Price : $8.95]
Federal Register notice: FDA establishes a docket to solicit comments on the content of Appendix A in the 7/2018 guidance for indu...[ Price : $8.95]
A new drug pricing analysis finds that for drugs launched so far this year, their median pricing ($257,000) is 43% more than the m...[ Price : $8.95]
FDA issues Emergent BioSolutions an 8/10 Warning Letter after a February inspection cites GMP issues at its Camden, MD manufacturi...[ Price : $8.95]
French national and Hexim Pharmaceuticals chief executive officer Alain Bouaziz pleads guilty to making false statements to FDA to...[ Price : $8.95]
Gilead Sciences files a sBLA for Trodelvy (sacituzumab govitecan-hziy), seeking expanded approval in patients with HR+/HER2- metas...